pre-seed
Stage
2
Investors
About
Arclight Therapeutics is a preclinical stage biotechnology company developing novel small molecule therapeutics for the treatment of cancer. Their lead program targets the DNA damage response pathway.
Explore Arclight Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.